Shield Therapeutics (LSE:STX) Net Margin % : -290.84% (As of Jun. 2023)

Shield Therapeutics Net Margin % Chart

Shield Therapeutics Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22
Net Margin %		Get a 7-Day Free Trial				-15.08	-1,223.92	-25.32	-1,295.46	-905.40

Shield Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Net Margin %	Get a 7-Day Free Trial													-1,514.14	-1,194.12	-578.35	-1,366.76	-290.84

Competitive Comparison of Shield Therapeutics's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Shield Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shield Therapeutics's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shield Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Shield Therapeutics's Net Margin % falls into.

Shield Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Shield Therapeutics's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Shield Therapeutics's Net Margin for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shield Therapeutics  (LSE:STX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Shield Therapeutics Net Margin % Related Terms

Thank you for viewing the detailed overview of Shield Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shield Therapeutics (LSE:STX) Business Description